POINT ROBERTS, Wash. and DELTA, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at continued growth in the CBD pet industry and potential movers in the space.
Canopy Growth Corporation (TSX: WEED.TO) (NYSE: CGC), always a strong market indicator, partnered with Sequential Brands Group, Inc. to announce that Martha Stewart has joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories, one of which is the rapidly growing pet wellness category.
"I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living," said Martha Stewart. "I'm especially looking forward to our first collaboration together, which will offer sensible products for people's beloved pets."
Canopy Growth is not taking this sector lightly, having previously reported that it will invest between $100 and $150 million in a hemp industrial park in New York State with the intended purpose of being the Company's first hemp facility in the United States.
Linkreservations Inc. (OTC: LRSV), a provider of cannabidiol (CBD) products specifically tailored for pets, today announced plans to change the name of the Company to LinkResPet. The new rebrand will follow a restructuring and new focus on the holistic petcare market, specifically cannabinoid (CBD) products tailored for pets.
This follows news recently announced the acquisition of an e-commerce website called www.LinkResPet.com.
“The decision to change the company name comes as part of our change in direction as a business to focus on the petcare and CBD industries. Both markets are seeing a big boost in demand and good quality response for both, so it is a great time to enter the market with products that will truly make a difference,” said Rene Lauritsen, CEO at LinkResPet. “Our mission is to provide the best quality CBD solutions for pets, targeted at treating dogs, cats and horses – we want our name to reflect that commitment.”
Describing their brand on their site, LinkResPet says,”Our CBD products can help pets in a variety of ways: Allergies and Immune System, Hip and Joint Mobility, Anxiety and Comfort and Everyday Health and Wellness.”
Being one of the few, if not the only public company to include CBD horse products, LinkResPet notes, “When it comes to the use of CBD in horses, you can only use CBD supplements specifically designed for them, as they are large animals and regular supplements would be too minimal to be effective.”
Dixie Brands Inc. (CSE: DIXI.U), one of the cannabis industry's leading consumer packaged goods companies, recently announced that its pet wellness subsidiary, Therabis LLC is entering the feline market with hemp-based soft chews designed to promote stress relief. "Calm and QuietTM” soft chew treats will be Therabis' first product for cats, building upon its successful line of hemp-based treats and food toppers for dogs.
"We are introducing the first hemp-based, soft-chew cat treat that is targeting a specific indication – in this case stress," said Bob Rubin, President of Therabis. "Our goal is to ease stress in cats and help them maintain a calm demeanor in situations that may cause them to be apprehensive. Pets are members of our families, and we believe people will respond very favorably to an all-natural product that can help improve their cats' quality of life."
SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF), has taken notice of this growing segment, having announced the formation of a new international hemp-focused subsidiary, Heavenly Rx Ltd.
Heavenly Rx intends to hold controlling ownership interests in various industry-leading assets in the hemp/CBD and THC-free cannabinoid wellness space, with an initial focus on hemp cultivation, processing and the manufacturing of a diverse range of traditional CBD products including oils, tinctures, balms, and vape-ready products. Additionally, Heavenly Rx intends to include several proprietary brands across numerous consumer product group verticals such as cosmetics and beauty products, bath and body products, infused foods (subject to governmental approvals and/or compliance) and a number of pet-related products.
As more pet owners become increasingly concerned with their pets overall health, including mental and physical, (as opposed to simply physical) and nutrition, the Hemp and CBD space continues to gain traction and we will continue to see more natural, healthy products come to market to help improve the overall lives of our four-footed family members.
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
https://www.investorideas.com/About/
Follow our Cannabis Social Media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/
Disclaimer/Disclosure: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring Link Reservations Inc. (LRSV) is a paid for service on Investorideas.com. Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: https://www.bcsc.bc.ca/release.aspx?id=6894
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411